Cargando…

Integrity of plasma cell-free DNA as a prognostic factor for vaccine therapy in patients with endometrial cancer

Endometrial cancer is the most prevalent gynecological cancer in developed countries. Although the prognosis of endometrial cancer is better than that of other gynecological cancers, the prognosis of advanced endometrial cancer is still poor and thus new therapeutic modalities, such as immune therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waki, Kayoko, Yokomizo, Kanako, Kawano, Kouichiro, Tsuda, Naotake, Komatsu, Nobukazu, Yamada, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783719/ https://www.ncbi.nlm.nih.gov/pubmed/33414910 http://dx.doi.org/10.3892/mco.2020.2191

Ejemplares similares

Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients
por: Waki, Kayoko, et al.
Publicado: (2020)

CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine‐treated ovarian cancer patients
por: Waki, Kayoko, et al.
Publicado: (2020)

Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer
por: Waki, Kayoko, et al.
Publicado: (2017)

Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy
por: Kawano, Kouichiro, et al.
Publicado: (2015)

Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides
por: Fukui, Akimasa, et al.
Publicado: (2012)

Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth
por: Yokomizo, Kanako, et al.
Publicado: (2022)

Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
por: Ushijima, Kimio, et al.
Publicado: (2013)

Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
por: Tsuda, Naotake, et al.
Publicado: (2014)

Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia
por: Kawano, Kouichiro, et al.
Publicado: (2016)

Blockade of high mobility group box 1 augments antitumor T‐cell response induced by peptide vaccination as a co‐adjuvant
por: Waki, Kayoko, et al.
Publicado: (2016)

PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer
por: Waki, Kayoko, et al.
Publicado: (2014)

Epithelial borderline ovarian tumor: Diagnosis and treatment strategy
por: Ushijima, Kimio, et al.
Publicado: (2015)

Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology
por: Ushijima, Kimio, et al.
Publicado: (2023)

Suppression of high mobility group box 1 in B16F10 tumor does not inhibit the induction of neoantigen‐specific T cells
por: Waki, Kayoko, et al.
Publicado: (2022)

Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients
por: Suekane, Shigetaka, et al.
Publicado: (2020)

Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine
por: Koga, Noriko, et al.
Publicado: (2017)

DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers
por: Kato, Masafumi, et al.
Publicado: (2015)

Endometrial regeneration with endometrial epithelium: homologous orchestration with endometrial stroma as a feeder
por: Yokomizo, Ryo, et al.
Publicado: (2021)

Concentrations of Plasma Nucleosomes but Not Cell-Free DNA Are Prognostic in Dogs Following Trauma
por: Letendre, Jo-Annie, et al.
Publicado: (2018)

Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy
por: Zhu, Feng, et al.
Publicado: (2021)

Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis
por: Takeda, Takashi, et al.
Publicado: (2016)

Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine
por: Yutani, Shigeru, et al.
Publicado: (2013)

Integration of Molecular Data in the Prognostic Stratification and Management of Endometrial Carcinoma
por: Raffone, Antonio, et al.
Publicado: (2022)

Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2018)

Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
por: Chen, Xiaoji, et al.
Publicado: (2021)

Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele
por: Sakamoto, Shinjiro, et al.
Publicado: (2015)

Identification of Somatic Mutations in Papanicolaou Smear DNA and Plasma Circulating Cell-Free DNA for Detection of Endometrial and Epithelial Ovarian Cancers: A Pilot Study
por: Jiang, Xuan, et al.
Publicado: (2020)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
por: Fernandez-Garcia, Daniel, et al.
Publicado: (2019)

Clinicopathologic vs. Molecular Integrated Prognostication of Endometrial Carcinoma by European Guidelines
por: Loukovaara, Mikko, et al.
Publicado: (2022)

Prediction of the efficacy of immunotherapy by measuring the integrity of cell‐free DNA in plasma in colorectal cancer
por: Kitahara, Masahiro, et al.
Publicado: (2016)

Integrity and Quantity Evaluation of Plasma Cell-Free DNA in Triple Negative Breast Cancer
por: Salimi, Mahdieh, et al.
Publicado: (2019)

The level and integrity of plasma circulating cell-free DNA in patients with primary multiple myeloma
por: Shen, Qian, et al.
Publicado: (2022)

High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2018)

Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer
por: Iqbal, Sobuhi, et al.
Publicado: (2015)

Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A11(+) or ‐A33(+) allele
por: Sakamoto, Shinjiro, et al.
Publicado: (2017)

Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients
por: Tejerizo-García, Álvaro, et al.
Publicado: (2013)

Is Tumor-Free Distance an Independent Prognostic Factor for Early-Stage Endometrioid Endometrial Cancer?
por: Oge, Tufan, et al.
Publicado: (2020)

Circulating cell-free DNA content as blood based biomarker in endometrial cancer
por: Cicchillitti, Lucia, et al.
Publicado: (2017)

Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer
por: Cui, Zhiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ecl12g57iobcgkp288i2jt27dv